Delivery Order SPE2DB24D2003-SPE2DB26FXCW1
- Not listed
- The Defense Logistics Agency awarded a $1,918.21 delivery order to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal insert (18 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed price contract, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, represents a competitively awarded non-set-aside delivery order. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,223.68 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count package). This firm fixed price delivery order, which represents a non-competitive set-aside award, is scheduled for completion by September 19, 2025, with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government,...
- The Defense Logistics Agency awarded a delivery order valued at $4,543.33 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count) on September 25, 2025, with a completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within the company's...
- The Defense Logistics Agency awarded a $1,748.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (8-count packaging). The delivery order, which concludes on September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made through open...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,054.25 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 22, 2025, with completion targeted for October 23, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and runs through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order valued at $1,197.71 to AmerisourceBergen Drug Corp on August 11, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 12, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,835.24 to AmerisourceBergen Drug Corp for Yuvafem 10 MCG vaginal inserts (18 count) on October 17, 2025, with completion scheduled for October 20, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,946.09 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Yuvafem 10 mcg vaginal inserts (18-count). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,607.76 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (18 count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price contract, classified as a non-set-aside award, will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.12 to AmerisourceBergen Drug Corp on September 22, 2025, for Yuvafem 10 mcg vaginal inserts (18-count). This competitively awarded, firm fixed-price delivery order is classified as non-set-aside and requires completion by September 23, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB26FXCW1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,752.65 to AmerisourceBergen Drug Corp for Yuvafem 10 mcg vaginal inserts (8-count package) on October 30, 2025, with an ultimate completion date of October 31, 2025. This competitively awarded, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under a larger procurement vehicle. No set-aside designation was used for this award. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications and medical commodities to military healthcare programs and other federal healthcare systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills federal medical procurement needs through DLA, delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare products across multiple therapeutic areas in support of Defense Health Agency operations and other federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/30/25 |